Correlation Between Pieris Pharmaceuticals and Corvus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Pieris Pharmaceuticals and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and Corvus Pharmaceuticals.
Diversification Opportunities for Pieris Pharmaceuticals and Corvus Pharmaceuticals
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pieris and Corvus is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and Corvus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pieris Pharmaceuticals and Corvus Pharmaceuticals
Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to under-perform the Corvus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pieris Pharmaceuticals is 2.46 times less risky than Corvus Pharmaceuticals. The stock trades about -0.15 of its potential returns per unit of risk. The Corvus Pharmaceuticals is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 756.00 in Corvus Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 138.00 from holding Corvus Pharmaceuticals or generate 18.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pieris Pharmaceuticals vs. Corvus Pharmaceuticals
Performance |
| Timeline |
| Pieris Pharmaceuticals |
| Corvus Pharmaceuticals |
Pieris Pharmaceuticals and Corvus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pieris Pharmaceuticals and Corvus Pharmaceuticals
The main advantage of trading using opposite Pieris Pharmaceuticals and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.| Pieris Pharmaceuticals vs. CytomX Therapeutics | Pieris Pharmaceuticals vs. Instil Bio | Pieris Pharmaceuticals vs. Spero Therapeutics | Pieris Pharmaceuticals vs. Assembly Biosciences |
| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |